Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
WALD
WALD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
WALD News
Obagi Partners with DermFx for ALOHA Program Launch
Feb 06 2026
Newsfilter
Obagi Partners with Moxie to Launch ALOHA Program
Feb 05 2026
Newsfilter
Obagi Launches New Lip Care Innovations
Feb 03 2026
Newsfilter
Obagi Partners with VIO Med Spa to Launch ALOHA Program
Jan 30 2026
Newsfilter
Waldencast Faces Securities Fraud Claims, Shares Drop 6.49%
Jan 08 2026
PRnewswire
Waldencast Faces Securities Fraud Claims, Shares Drop 6.49%
Jan 06 2026
Globenewswire
Waldencast Faces Securities Fraud Investigation, Shares Drop 6.49%
Jan 01 2026
PRnewswire
Waldencast Under Investigation Amid $185.2M Loss in H1 2025
Dec 11 2025
PRnewswire
Recent Developments Influencing the Waldencast Investment Narrative
Nov 29 2025
Yahoo Finance
Canaccord Genuity Keeps Buy Rating on Waldencast, Reduces Price Target to $4
Nov 25 2025
Benzinga
Telsey Advisory Group Lowers Waldencast Rating to Market Perform, Keeps Price Target at $3
Nov 25 2025
Benzinga
Dow Rises by 300 Points; Waldencast Stock Takes a Dive
Nov 24 2025
Benzinga
Novo Nordisk, Waldencast, and Other Major Stocks Decline in Pre-Market Trading on Monday
Nov 24 2025
Benzinga
Waldencast Reports 5.6% Revenue Growth to $66.8M in Q2 2025
Nov 24 2025
Newsfilter
Waldencast Reports Decrease in Q2 Adjusted EBITDA and Provides Q3 Trading Update
Nov 24 2025
NASDAQ.COM
Obagi Medical Presents New Clinical Findings on Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Nov 16 2025
Yahoo Finance
Show More News
